Our research in this area centers around targeted drug delivery to organ systems and temporally stationed residence devices that can systematically deliver drugs or provide relief to the organ system.

Ingestible devices will perform drug delivery to a target location in the GI tract while residency devices can be intentionally retained to periodically deliver drugs in the digestive system. An example of this will be a proton pump inhibitor dispenser to decreases the amount of acid produced in the stomach. This is relevant for patients suffering from gastroesophageal reflux disease (GERD).